REPAGLINIDE Tablet Ref.[7858] Active ingredients: Repaglinide

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Accord-UK Ltd, Whiddon Valley, Barnstaple, Devon, EX32 8NS

Product name and form

Repaglinide 0.5 mg Tablets.

Pharmaceutical Form

Tablet.

Repaglinde 0.5 mg Tablets are white, round, biconvex and engraved with RE on one side.

Qualitative and quantitative composition

Each tablet contains 0.5 mg of repaglinide.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Repaglinide

Repaglinide is a short-acting oral secretagogue. Repaglinide lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning β-cells in the pancreatic islets.

List of Excipients

Microcrystalline cellulose (E460)
Calcium hydrogen phosphate, anhydrous
Poloxamer
Povidone
Glycerol 85%
Meglumine
Polacrilin potassium
Maize starch
Magnesium stearate

Pack sizes and marketing

Blisters (Aluminium/Aluminium).

Pack sizes: 30, 60, 90, 100, 120 and 180 tablets

Plastic (polyethylene) container with desiccant canister (filled with silica gel).

Pack sizes: 100 tablets

Not all pack sizes may be marketed.

Marketing authorization holder

Accord-UK Ltd, Whiddon Valley, Barnstaple, Devon, EX32 8NS

Marketing authorization dates and numbers

PL 0142/1010

09/04/2010
05/11/2015

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.